2Cabrera J,Cabrera J Jr,Garcia-Olmedo MA,et al.Treatment of venous malformations with sclerosant in microfoam form.Arch Dermatol,2003,139(11):1409-1416.
3Gues JJ,Allaert FA,Gillet JL,et al.Immediate and midterm complication of sclerotherapy session.Deromatol Surg,2005,31(2):123-128.
4Labas P,Ohradka B,Cambal M,Reis R,et al.Long term results of compression sclerotherapy.Bratisl Lek Listy,2003,104(2):78-81.
6Beale RJ, Gough MJ. Treatment options for primary varicose veins: a review [ J ]. Eur J Vasc Endovasc Surg,2005,30( 1 ) :83-95.
7Hirai M, Lwata H, Sawazaki N. Comparision of recurrence rate and hemodynamic effect a- mong various technical approaches for liga- tions of saphenous vein in treatment of vari- cose veins [ J ]. VASA, 2007,36 ( 1 ) : 23- 27.
8Carradice D, Mekako A I, Hatfield J, et al. Randomized clinical trial of concomitant or sequential phlebectomy after wndovenous la-ser therapy for varicose veins [ J ]. British Fournal of Surgery,2009,96 (4) : 375-396.
9Theivacumar NS, Darwood R J, Gough MJ. Endovenous laser ablation (EVLA) of the an- terior accessory great saphenous vein (AAGSV) :abolition of sapheno-femoral re- flux with preservation of the great saphenous vein[J]. Eur J Vasc Surg, 2009,37 (4) : 477-481.
10Bergan J J, Pascarella L. Severe chronic ve- nous in sufficiency: primary treatment with sclerofoam [ J ]. Sem in Vasc Surg, 2005,18 ( 1 ) :49-56.
